Arcus Biosciences Stock Quote RCUS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

15.60

Bid

Ask

Volume

0.00 Day's Range 0.00

12.95 52 Week Range 20.31

Market Cap

1.426B

Previous Close

15.60

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

563,147

Shares Outstanding

91,427,505

Dividend Yield

PE Ratio

-4.65

Earnings Per Share (EPS)

-3.36

Revenue

117M

Net Profit

-307M

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule... Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.arcusbio.com

Headquarters

Camden, Delaware, USA

Founded

Arcus Biosciences Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker RCUS. The last closing price for Arcus Biosciences was $15.60. Over the last year, Arcus Biosciences shares have traded in a share price range of $ 12.95 to $ 20.31.

Arcus Biosciences currently has 91,427,505 shares outstanding. The market capitalization of Arcus Biosciences is $1.43 billion. Arcus Biosciences has a price to earnings ratio (PE ratio) of -4.65.

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today...

FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.14	-6.81003584229	16.74	17.31	15.32	707930	16.2631355	CS
4	-1.73	-9.98268897865	17.33	18.275	15.3	530210	16.66627053	CS
12	0.78	5.26315789474	14.82	18.75	13.52	563147	15.91506317	CS
26	-0.87	-5.28233151184	16.47	19.11	13.52	644466	16.08920102	CS
52	-4.01	-20.4487506374	19.61	20.31	12.95	737801	16.5228101	CS
156	-20.42	-56.6907273737	36.02	49.1	12.95	858678	23.08307844	CS
260	6.86	78.4897025172	8.74	49.1	7.19	719947	23.95294522	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ZKHZKH Group Limited	$ 3.14 (13.77%)	6
EBSEmergent Biosolutions Inc	$ 6.82 (11.62%)	318.23k
NMCONuveen Municipal Credit Opportunities Fund	$ 13.00 (11.49%)	10
RBOTVicarious Surgical Inc	$ 6.00 (9.89%)	10
SOLEmeren Group Ltd	$ 2.49 (6.87%)	975
BKSYBlackSky Technology Inc	$ 4.13 (-18.06%)	39.46k
VNCEVince Holding Corp	$ 1.75 (-6.91%)	14
KBHKB Home	$ 82.00 (-6.21%)	78.31k
NRGVEnergy Vault Holdings Inc	$ 0.96 (-5.88%)	93
XPEVXPeng Inc	$ 10.18 (-4.86%)	492.14k
NIONIO Inc	$ 5.73 (-3.54%)	2.57M
FFord Motor Company	$ 10.63 (-2.21%)	621.1k
BABAAlibaba Group Holding Limited	$ 94.38 (-2.89%)	546.48k
XPEVXPeng Inc	$ 10.18 (-4.86%)	492.14k
RITMRithm Capital Corp	$ 11.38 (-3.64%)	424.72k